{"created":"2023-07-25T10:25:17.993464+00:00","id":5548,"links":{},"metadata":{"_buckets":{"deposit":"ee392e6b-1cf2-4c92-972b-c63a0d26a5dc"},"_deposit":{"created_by":15,"id":"5548","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"5548"},"status":"published"},"_oai":{"id":"oai:air.repo.nii.ac.jp:00005548","sets":["611:939:940"]},"author_link":["15666","15667","15668","15669"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"3184","bibliographicPageStart":"3179","bibliographicVolumeNumber":"14","bibliographic_titles":[{"bibliographic_title":"Neuropsychiatric Disease and Treatment","bibliographic_titleLang":"en"}]}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Dovepress"}]},"item_10001_relation_25":{"attribute_name":"関連情報","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"Version of record (open access)"}],"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.2147/NDT.S184081","subitem_relation_type_select":"DOI"}}]},"item_10001_rights_15":{"attribute_name":"権利情報","attribute_value_mlt":[{"subitem_rights":"© 2018 Takeshima et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php　and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).　"}]},"item_10001_version_type_20":{"attribute_name":"出版タイプ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_1724099666130":{"attribute_name":"収録物識別子","attribute_value_mlt":[{"subitem_source_identifier":"11782021","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"作成者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Takeshima, Masahiro","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"15666","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ishikawa, Hiroyasu","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"15667","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Kanbayashi, Takashi","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"15668","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Shimizu, Tetsuo","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"15669","nameIdentifierScheme":"WEKO"}]}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"clinical trial","subitem_subject_scheme":"Other"},{"subitem_subject":"antipsychotic agents","subitem_subject_scheme":"Other"},{"subitem_subject":"restless legs syndrome","subitem_subject_scheme":"Other"},{"subitem_subject":"schizophrenia","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"15","path":["940"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2022-01-07"},"publish_date":"2022-01-07","publish_status":"0","recid":"5548","relation_version_is_last":true,"title":["Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2024-08-24T22:36:54.248222+00:00"}